Latest Bionic eye Companies Updates:
Pixium Vision Received a breakthrough device designation from the US FDA for their Prima System, a bionic eye implant designed to restore basic vision for patients with dry AMD. This paves the way for expedited review and potential approval in the US.Partnered with leading hospitals and eye clinics to expand clinical trials and access to the Prima System for patients worldwide.
Second Sight Medical Products Announced positive results from a long-term follow-up study of their Argus II Retinal Prosthesis System, demonstrating sustained visual improvements and patient satisfaction over several years.Focused on developing the next generation of bionic eye implants with enhanced features and improved functionality.
Bionic Vision Australia Secured AUD 30 million in funding from the Australian government to support the development and commercialization of their bionic eye system, the Bionic Vision Australia system.Continued clinical trials with encouraging results demonstrating potential for restoring functional vision in patients with retinitis pigmentosa.
iBionics Announced the launch of their new bionic eye platform, the eMacular, designed for a wider range of retinal diseases beyond AMD.Partnered with research institutions to explore applications of bionic eyes in treating other neurological conditions.
Zimmer Biomet Acquired a company developing advanced neural interface technology, potentially accelerating the development of next-generation bionic eye systems with improved nerve stimulation and visual perception.Emphasized their commitment to investing in innovative technologies for restoring vision and improving quality of life for patients with visual impairments.
List of Bionic eye Key companies in the market
- Monash Vision Group
- Second Sight Medical Products
- LLPixium Vision
- Nidek Co. Ltd.
- MetaModal LLC
- Bionic Vision Technologies
- Biomedical Technologies S.L